The Sarah Cannon Research Institute — Nashville, Tennessee

The Sarah Cannon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

The Sarah Cannon Research Institute has participated in 43 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent.

Sponsors: Inspirna, Inc., Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sarah Cannon Research Institute?

The Sarah Cannon Research Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sarah Cannon Research Institute conducted?

The Sarah Cannon Research Institute has 43 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent.

Is The Sarah Cannon Research Institute accredited by Crixeo Health?

Yes — The Sarah Cannon Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.